Page 5 - Yusri Elsayed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Longtime BioMarin CEO hands off baton—Chutes & Ladders

Longtime BioMarin CEO hands off baton—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Ocuphire pharmaAmit mehtaDerrell porterKirsty sempleErin lavelleCellevolve bioSarah coleTodd dickinsonAdrian rayPaul frohnaMichelle shuffettJennifer towneMarguerite hutchinsonChristian howellLori kunkelDaiichi sankyo plexxikon

Janssen signs $245m deal with Cellular Biomedicine for pair of CAR T-cell therapies

Janssen signs $245m deal with Cellular Biomedicine for pair of CAR T-cell therapies
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Yusri elsayedTony bizuo liuCellular biomedicine groupJanssen research developmentDrug administrationJanssen pharmaceutical companies of johnsonJanssen pharmaceutical companiesGreater chinaJanssen research

Janssen strikes $245M licensing deal with Cellular Biomedicine Group for CAR-T cancer therapies

Janssen’s licensing agreement with Cellular Biomedicine Group will give it access to two CAR-T assets, including C-CAR039.

Sen zhuangYusri elsayedTony liuJohnson janssenDrug administrationJanssen research developmentCellular biomedicine groupJanssen biotechJanssen researchRegenerative medicine advanced therapyFast track designation

Janssen Enters Worldwide Collaboration and License Agreement with Cellular Biomedicine Group to Develop Next Generation CAR-T Therapies

Janssen Enters Worldwide Collaboration and License Agreement with Cellular Biomedicine Group to Develop Next Generation CAR-T Therapies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Satu glaweSen zhuangObrian kenneyYusri elsayedNone of janssen biotech incExchange commissionClinical researchCellular biomedicine groupJanssen research developmentCellular biomedicine group incCompanies of johnsonJanssen pharmaceutical companies of johnsonJanssen pharmaceutical companiesDrug administrationPrnewswire janssen biotech incJanssen biotech inc

Janssen to develop next-gen CAR-T therapies via agreement with Cellular Biomedicine Group

Janssen Biotech has entered into a worldwide collaboration and license agreement with Cellular Biomedicine Group to develop, manufacture and commercialize next-generation chimeric antigen receptor (CAR) T-cell therapies for the treatment of B-cell malignancies.

Yusri elsayedJanssen research developmentCellular biomedicine groupDrug administrationJanssen pharmaceutical companiesCellular biomedicineGreater chinaWestern europeInvestigational new drugRegenerative medicine advanced therapyFast trackVice presidentDisease area leaderHematologic malignanciesJanssen researchBio developments